Literature DB >> 10323884

Molecular screening of patients with long standing extensive ulcerative colitis: detection of p53 and Ki-ras mutations by single strand conformation polymorphism analysis and differential hybridisation in colonic lavage fluid.

S M Lang1, D F Stratakis, M Heinzlmann, W Heldwein, B Wiebecke, K Loeschke.   

Abstract

BACKGROUND: In patients with long standing ulcerative colitis at risk of developing malignancy, mutations of the p53 and Ki-ras gene were investigated in lavage solution obtained at surveillance colonoscopy.
METHODS: DNA was isolated from 31 consecutive patients with total or subtotal ulcerative colitis and a disease duration of between seven and 26 years. Twenty seven control patients showed no macroscopic or microscopic inflammation on colonoscopy. Exons 5-8 of the p53 gene and exon 1 of the Ki-ras gene were amplified by polymerase chain reaction. Mutations of the p53 gene were detected by single strand conformation polymorphism analysis. Point mutations of the Ki-ras gene were hybridised on dot blots with oligonucleotides marked with digoxigenin.
RESULTS: In all cases of ulcerative colitis and in all of the 27 control patients, wild type p53 and wild type Ki-ras could be detected. In four patients with ulcerative colitis, a mutation in exon 5 to 7 of the p53 gene was found, and two patients had a mutation of the Ki-ras gene (Gly to Asp-12, Gly to Val-12). None of these patients had dysplasia in serial biopsy specimens, and all but one had had the disease for more than 10 years. One control patient had a mutation.
CONCLUSIONS: Mutations were more frequent in patients with long standing ulcerative colitis (19%) than in control patients (3%, p = 0.07). The technique may be useful for screening for early malignancy in ulcerative colitis.

Entities:  

Mesh:

Year:  1999        PMID: 10323884      PMCID: PMC1727550          DOI: 10.1136/gut.44.6.822

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Ulcerative colitis and colorectal cancer. A population-based study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

2.  Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.

Authors:  P Gomes; C du Boulay; C L Smith; G Holdstock
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

3.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.

Authors:  D Sidransky; T Tokino; S R Hamilton; K W Kinzler; B Levin; P Frost; B Vogelstein
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

4.  Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.

Authors:  S M Lang; M Heinzlmann; D F Stratakis; W Teschauer; K Loeschke
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

5.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

6.  Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.

Authors:  P M Choi; F W Nugent; D J Schoetz; M L Silverman; R C Haggitt
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

7.  Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.

Authors:  J E Lennard-Jones; D M Melville; B C Morson; J K Ritchie; C B Williams
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

8.  Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma.

Authors:  M Tobi; F C Luo; Z Ronai
Journal:  J Natl Cancer Inst       Date:  1994-07-06       Impact factor: 13.506

9.  Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.

Authors:  B A Lashner; M D Silverstein; S B Hanauer
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

10.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.

Authors:  P Boukamp; R T Petrussevska; D Breitkreutz; J Hornung; A Markham; N E Fusenig
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  6 in total

1.  Association of p53 codon 72 genetic polymorphism with the risk of ulcerative colitis in northern Iran.

Authors:  Salaheddin Vaji; Zivar Salehi; Keyvan Aminian
Journal:  Int J Colorectal Dis       Date:  2010-07-29       Impact factor: 2.571

Review 2.  Inflammatory bowel disease and carcinogenesis.

Authors:  Hiroko Nagao-Kitamoto; Sho Kitamoto; Nobuhiko Kamada
Journal:  Cancer Metastasis Rev       Date:  2022-04-13       Impact factor: 9.237

3.  How does inflammation drive mutagenesis in colorectal cancer?

Authors:  Chia Wei Hsu; Mark L Sowers; Willie Hsu; Eduardo Eyzaguirre; Suimin Qiu; Celia Chao; Charles P Mouton; Yuri Fofanov; Pomila Singh; Lawrence C Sowers
Journal:  Trends Cancer Res       Date:  2017

4.  Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.

Authors:  Davy Carlos Mendes Rapozo; Ana Braunstein Grinmann; Ana Teresa Pugas Carvalho; Heitor Siffert P de Souza; Sheila Coelho Soares-Lima; Tatiana de Almeida Simão; Daurita de Paiva; Flávio Abby; Rodolpho Mattos Albano; Luiz Felipe Ribeiro Pinto
Journal:  Int J Colorectal Dis       Date:  2009-06-20       Impact factor: 2.571

Review 5.  Colitis-associated neoplasia: molecular basis and clinical translation.

Authors:  Sebastian Foersch; Markus F Neurath
Journal:  Cell Mol Life Sci       Date:  2014-05-15       Impact factor: 9.261

6.  TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis.

Authors:  Mariann Friis-Ottessen; Espen Burum-Auensen; Aasa R Schjølberg; Per Olaf Ekstrøm; Solveig N Andersen; Ole Petter Clausen; Paula M De Angelis
Journal:  Int J Mol Med       Date:  2014-10-20       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.